Huang, Yu-Chung <br/><br/>
Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma.  [electronic resource] 

 -  Annals of hematology  Oct 2011 
 - 1145-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-011-1268-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>China--epidemiology<br/>Cohort Studies<br/>Disease Susceptibility--chemically induced<br/>Drug Monitoring<br/>Female<br/>Humans<br/>Incidence<br/>Lung Diseases, Interstitial--complications<br/>Lymphocyte Count<br/>Lymphoma, Large B-Cell, Diffuse--blood<br/>Lymphopenia--etiology<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Risk Factors<br/>Rituximab<br/>Survival Analysis